Profile_bird

Hey there! Arthritis_News is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving Arthritis_News's tweets.

Already using Twitter
from your phone? Click here.

Arthritis_News

  1. Arthritis News: McNeil Consumer Healthcare announces recall of TYLENOL in bottles with red EZ-OPEN CAP: In consulta... http://bit.ly/5VsnUQ
  2. Arthritis News: New Thermal-Aid products reduce pain and swelling in arthritis patients: Pacific Shore Holdings, In... http://bit.ly/7dBdTa
  3. Arthritis News: European CHMP announces positive opinion for Amgen's Prolia marketing authorization: Amgen Inc. tod... http://bit.ly/7yQAZ5
  4. Arthritis News: GSK receives European CHMP positive opinion for Revolade: Ligand Pharmaceuticals Incorporated today... http://bit.ly/7gYP37
  5. Arthritis News: Ligand Pharmaceuticals, Neurogen revise merger agreement: Ligand Pharmaceuticals Incorporated and N... http://bit.ly/7Ra9r4
  6. Arthritis News: Umbilical cord stem cells may be useful in treating blood disorders: Stem cells that could one day ... http://bit.ly/53xaCC
  7. Arthritis News: Immuno Laboratories and TRPN sign agreement to reduce chronic illness: Immuno Laboratories, a leadi... http://bit.ly/7xhgzO
  8. Arthritis News: 2010 Dr. Paul Janssen Award for Biomedical Research open for nomination: The Dr. Paul Janssen Award... http://bit.ly/6dRMzS
  9. Arthritis News: UAB professors honored for scientific contributions and outstanding mentorship: Three University of... http://bit.ly/7qMLco
  10. Arthritis News: Forest Laboratories Holdings and Almirall to develop, market and distribute LAS100977 in the US: Fo... http://bit.ly/6tws4U
  11. Arthritis News: ASA offers practical ways for sufferers to take active role in treatment of pain: Whether the resul... http://bit.ly/4ORwMe
  12. Arthritis News: La Jolla Institute for Allergy & Immunology awarded $18.8M NIH grant for infectious diseases study:... http://bit.ly/70kywL
  13. Arthritis News: Top-line efficacy and safety results from Phase 2b clinical trial of XIAFLEX announced: BioSpecific... http://bit.ly/4V3xom
  14. Arthritis News: ChemoCentryx commences enrollment in CCX354 Phase 2 clinical trial for RA: ChemoCentryx, Inc. today... http://bit.ly/7LlJ9c
  15. Arthritis News: Amgen receives worldwide rights to Array’s small-molecule glucokinase activator program: Array Bi... http://bit.ly/6LVovy
  16. Arthritis News: Study suggests combining Celebrex with low-dose aspirin may prevent blood clots: Millions of Americ... http://bit.ly/8JPelV
  17. Arthritis News: Medicare power mobility remains a viable option for beneficiaries: Across America, seniors, togethe... http://bit.ly/8w3C3Y
  18. Arthritis News: Celgene announces positive data from its apremilast Phase IIb study for plaque-type psoriasis: Celg... http://bit.ly/8kgE4W
  19. Arthritis News: Femta Pharmaceuticals, Lonza Group collaborate in cGMP production of FM101 antibody: Femta Pharmace... http://bit.ly/4tdusT
  20. Arthritis News: NICE guidelines limit options for low cost osteoporosis drugs: Low cost osteoporosis drugs are stri... http://bit.ly/4LNQjO